T1	Participants 84 145	chemo-naïve patients with advanced non-small cell lung cancer
T2	Participants 290 338	chemo-naïve non-small cell lung cancer patients.
T3	Participants 347 453	Patients with chemo-naïve stage IIIB/IV non-small cell lung cancer were randomized into two treatment arms
T4	Participants 658 707	A total of 80 patients were entered in this trial
